Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/childhood-acute-lymphoblastic-leukemia/descriptif_3959769
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3959769

Childhood Acute Lymphoblastic Leukemia, Softcover reprint of the original 1st ed. 2017

Langue : Anglais

Coordonnateur : Vora Ajay

Couverture de l’ouvrage Childhood Acute Lymphoblastic Leukemia

This book provides a comprehensive and up-to-date review of all aspects of childhood Acute Lymphoblastic Leukemia, from basic biology to supportive care. It offers new insights into the genetic pre-disposition to the condition and discusses how response to early therapy and its basic biology are utilized to develop new prognostic stratification systems and target therapy.

Readers will learn about current treatment and outcomes, such as immunotherapy and targeted therapy approaches.  Supportive care and management of the condition in resource poor countries are also discussed in detail.

This is an indispensable guide for  research and laboratory scientists, pediatric hematologists as well as specialist nurses involved in the care of childhood leukemia.

Chapter 1
Title: Epidemiology including genetic predisposition
Authors: Professor Richard Houlston (richard.houlston@icr.ac.uk), Institute of Cancer Research, Royal Marsden, London and Professor Martin Stanulla (stanulla.martin@mh-hannover.de), Hannover University.
Chapter 2
Title: Clinical Features
Author: Dr Nicholas Goulden (Nicholas.goulden@gosh.nhs.uk), Great Ormond Street Hospital, London
Chapter 3
Title: Diagnostic flow cytometry and immunophenotypic classification
Author: Dr Dario Campana (paedc@nus.edu.sg), National University of Singapore.
Chapter 4
Title: Cytogenetics
Authors: Professor Anthony Moorman (anthony.moorman@newcastle.ac.uk) and Profes
sor Christine Harrison (christine.harrison@newcastle.ac.uk) both at Leukaemia Cytogenetics Reference Laboratory, Newcastle University.
Chapter 5
Title: Molecular genetics
Authors: Dr Charles Mullighan, St Jude’s Hospital, Memphis, USA
Chapter 6
Title: Pharmacology including pharmacokinetics, pharmacodynamics and pharmacogenetics
Author: Professor Mary Relling (mary.relling@stjude.org) St Jude’s Hospital, Memphis, USA
Chapter 7
Title: Minimal Residual Disease
Author: Jacques Van Dongen (vandongen@immu.fgg.eur.nl), Rotterdam University, NL
Chapter 8
Title: Treatment – first line
Author: Ajay Vor
a (ajay.vora@sch.nhs.uk) , Sheffield Children's NHS Trust, UK
Chapter 9
Title: Treatment – relapse
Author: Vaskar Saha (v.saha@manchester.ac.uk) , Manchester University, UK
Chapter 10
Title: Treatment
– new drugs
Author: Michel Zwaan (c.m.zwaan@erasmusmc.nl), Rotterdam, NL
Chapter 11
Title: Treatment – immune based approaches
Authors: Antibodies – Arend Von Stackelberg (Arend.Stackelberg@charite.de) , Charite Hospital, Berlin
Cellular therapy – Persis Amrolia (persis.amrolia@gosh.nhs.uk), Great Ormond Street Hospital, London, UK
Chapter 12
Title: Supportive care
Author: Deepa Bhojwani (deepa.b
hojwani@chla.org), UCLA, CA, USA
Chapter 13
Title: Developing world perspective
Author: Allen Yeoh

Professor Ajay Vora is honorary professor of paediatric haematology at University of Sheffield and consultant paediatric haematologist at Sheffield Children’s Hospital. His daily practice involves the care of children with a variety of malignant and non-malignant blood disorders. He has a special interest in childhood leukaemia and cord blood transplantation. He is chair of the UK NCRI childhood leukaemia sub-group and I-BFM ALL committee. He is chief investigator of childhood and infant ALL clinical trials and is involved with several research projects in this area. He is programme director of the Trent Regional Paediatric Haemopoeitic Stem Cell transplant service. 

Exhaustively reviews current therapeutic strategies and applications of precision medicine in ALL treatment

Provides scientists and clinicians with state of the art knowledge to guide their research and clinical management

Written by an international multidisciplinary team of authors

Date de parution :

Ouvrage de 342 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

Prix indicatif 137,14 €

Ajouter au panier

Date de parution :

Ouvrage de 342 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

Prix indicatif 94,94 €

Ajouter au panier